Companies: 10,795·Total market cap: $144.5T
Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUPNASDAQHealthcare● Active
$4.67
+$0.18(+4.01%)
Market Cap$25239253
P/E Ratio
52W High$21.4
52W Low$3.645
Overview

Neuphoria Therapeutics Inc.(NEUP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NEUP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$15.65M$0.00M$0.00M$0.38M$0.00M
Cost of Revenue$0.00M$0.66M$0.67M$16.00M$0.00M
Gross Profit$15.65M($0.66M)($0.67M)$0.38M$0.00M
Gross Margin %(computed)100.00%100.00%
Operating Expenses
R&D Expenses$9.01M$14.10M$19.67M$23.25M$4.33M
G&A Expenses$7.77M$12.69M$13.41M$11.13M$4.24M
Total Operating Expenses$16.78M$26.79M$33.09M$31.40M$8.96M
Operating Income($1.13M)($26.79M)($33.09M)($31.02M)($8.96M)
Operating Margin %(computed)-7.21%
Interest Income$0.17M$0.22M$0.32M$0.01M$0.00M
Interest Expense$0.00M$0.00M$0.03M$0.03M$1.08M
Income Before Tax($0.84M)($23.32M)($32.39M)($31.90M)($6.68M)
Income Tax Expense($0.47M)($0.13M)($0.21M)($0.28M)($0.14M)
Net Income($0.37M)($23.19M)($32.18M)($31.62M)($6.53M)
Net Margin %(computed)-2.36%
Per Share & EBITDA
EPS (Basic)$-0.23$-0.10$-0.18$-0.20$-0.10
Wtd Avg Shares1.62M149.80M122.39M112.78M65.00M
EBITDA($0.12M)($25.65M)($31.45M)($30.25M)($4.51M)
EBITDA Margin %(computed)-0.78%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Neuphoria Therapeutics Inc.

关于Neuphoria Therapeutics Inc.(NEUP)损益表

Neuphoria Therapeutics Inc.(NEUP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NEUP实现营收$0.02B,毛利润$0.02B(毛利率100.00%),净利润($0.00B)(净利率-2.36%)。

常见问题

NEUP · 4 问

Neuphoria Therapeutics Inc.(NEUP)2025财年营收为$0.02B,同比up—%。

NEUP revenueNEUP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09